Reducing the impact of tuberculosis transmission in institutions: beyond infection control measures.
Brewer
T F
TF
Department of Medicine, Brigham Hospital, Harvard Medical School, Boston, Massachusetts, USA. timothy.brewer@channing.harvard.edu
Heymann
S J
SJ
D000995:Antitubercular Agents / Q000627:therapeutic use; D001500:BCG Vaccine; D003428:Cross Infection / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D017053:Infection Control; D007538:Isoniazid / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000517:prevention & control* / Q000635:transmission*
D000995:Antitubercular Agents; D001500:BCG Vaccine; D007538:Isoniazid